Table 2 Characteristics of IPMN cases in the cohort (N = 51).
Variable | Benign1 IPMNs (n = 21) | Malignant2 IPMNs (n = 30) | pvalue |
|---|---|---|---|
Age at diagnosis, mean (SD)(yrs) | 68.4 (9.8) | 68.6 (10.3) | 0.939 |
Male: Female, n (%) | 8(38):13(62) | 19(63):11(37) | 0.075 |
Body mass index (BMI), mean (SD) | 26.5 (4.6) | 27.9 (4.6) | 0.355 |
Positive personal history of diabetes | 4 (19) | 4 (13) | 0.621 |
Positive personal history of chronic pancreatitis | 5 (24) | 9 (30) | 0.126 |
Had abdominal pain as presenting symptom | 7 (37) | 11 (37) | 0.165 |
Had weight loss as presenting symptom | 3 (14) | 8 (27) | 0.110 |
Had jaundice as presenting symptom | 1 (5) | 8 (27) | 0.012 |
Pre-operative serum CA 19-9 levels, mean (SD)(ng/mL) | 91 (314) | 692 (1493) | 0.125 |
Pre-operative serum albumin levels, mean (SD)(ng/mL) | 4.4 (0.98) | 3.9 (0.66) | 0.073 |
Predominant tumor location | |||
Pancreatic Head | 6 (29) | 14 (47) | |
Pancreatic Body or Tail | 14 (67) | 12 (40) | 0.013 |
Diffuse | 1 (5) | 4 (13) | |
Type of ductal communication | |||
Main duct or mixed | 4 (22) | 10 (30) | 0.003 |
Branch duct | 14 (78) | 4 (13) | |
Size of largest cyst on imaging, mean (range) (cm) | 2.8 (1.6) | 3.5 (1.4) | 0.145 |
Solid component or mural nodule | |||
Yes | 3 (14) | 8 (27) | |
No | 15 (71) | 6 (20) | 0.021 |
